Fecal immunochemical test program performance over 4 rounds of annual screening: A retrospective cohort study

Annals of Internal Medicine

Volumn 164, Issue 7, 2016, Pages 456-463

  Jensen, Christopher D ^a   Corley, Douglas A ^a   Quinn, Virginia P ^b   Doubeni, Chyke A ^c   Zauber, Ann G ^d   Lee, Jeffrey K ^e   Zhao, Wei K ^a   Marks, Amy R ^a   Schottinger, Joanne E ^b   Ghai, Nirupa R ^b   Lee, Alexander T ^f   Contreras, Richard ^b   Klabunde, Carrie N ^g   Quesenberry, Charles P ^a   Levin, Theodore R ^h   Mysliwiec, Pauline A ^h  

^a DIVISION OF RESEARCH   (United States)

^b KAISER PERMANENTE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f WOODLAND HILLS MEDICAL CENTER   (United States)

^g NATIONAL INSTITUTES OF HEALTH   (United States)

^h KAISER PERMANENTE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; COHORT ANALYSIS; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CANCER; COLORECTAL CARCINOMA; ENDOSCOPY; FECAL IMMUNOCHEMICAL TEST; FECES ANALYSIS; FEMALE; FOLLOW UP; HUMAN; IMMUNOCHEMISTRY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIGMOIDOSCOPY; ADENOMA; CHEMISTRY; COLORECTAL NEOPLASMS; EARLY CANCER DIAGNOSIS; FECES; IMMUNOASSAY; MIDDLE AGED; OCCULT BLOOD; PROCEDURES; SENSITIVITY AND SPECIFICITY;

ADENOMA; AGED; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FECES; FEMALE; HUMANS; IMMUNOASSAY; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OCCULT BLOOD; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 84962738269     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M15-0983     Document Type: Article

References (33)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59: 225-49. [PMID: 19474385] doi: 10.3322/caac.20006
2. Edwards BK, Ward E, Kohler BA, Eheman C, Zauber AG, Anderson RN, et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer. 2010;116: 544-73. [PMID: 19998273] doi: 10.1002/cncr.24760
3. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63: 11-30. [PMID: 23335087] doi: 10.3322/caac.21166
4. U.S. Preventive Services Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;149: 627-37. [PMID: 18838716]
5. Levin B, Lieberman DA, McFarland B, Andrews KS, Brooks D, Bond J, et al; American Cancer Society Colorectal Cancer Advisory Group. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: A joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology. 2008;134: 1570-95. [PMID: 18384785] doi: 10.1053/j.gastro.2008.02.002
6. Rex DK, Johnson DA, Anderson JC, Schoenfeld PS, Burke CA, Inadomi JM; American College of Gastroenterology. American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. Am J Gastroenterol. 2009;104: 739-50. [PMID: 19240699] doi: 10.1038/ajg.2009.104
7. Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, et al. Randomised controlled trial of faecal-occultblood screening for colorectal cancer. Lancet. 1996;348: 1472-7. [PMID: 8942775]
8. Kronborg O, Fenger C, Olsen J, Jørgensen OD, Søndergaard O. Randomised study of screening for colorectal cancer with faecaloccult- blood test. Lancet. 1996;348: 1467-71. [PMID: 8942774]
9. Mandel JS, Church TR, Ederer F, Bond JH. Colorectal cancer mortality: Effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst. 1999;91: 434-7. [PMID: 10070942]
10. Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med. 2000;343: 1603-7. [PMID: 11096167]
11. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 1993;328: 1365-71. [PMID: 8474513]
12. Levin B, Lieberman DA, McFarland B, Smith RA, Brooks D, Andrews KS, et al; American Cancer Society Colorectal Cancer Advisory Group. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: A joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin. 2008;58: 130-60. [PMID: 18322143] doi: 10.3322/CA.2007.0018
13. Zauber AG, Lansdorp-Vogelaar I, Knudsen AB, Wilschut J, van Ballegooijen M, Kuntz KM. Evaluating test strategies for colorectal cancer screening: A decision analysis for the U.S. Preventive Services Task Force. Ann Intern Med. 2008;149: 659-69. [PMID: 18838717]
14. Levin TR, Jamieson L, Burley DA, Reyes J, Oehrli M, Caldwell C. Organized colorectal cancer screening in integrated health care systems. Epidemiol Rev. 2011;33: 101-10. [PMID: 21709143] doi: 10.1093/epirev/mxr007
15. van Rossum LG, van Rijn AF, Laheij RJ, van Oijen MG, Fockens P, van Krieken HH, et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.Gastroenterology.2008;135: 82-90.[PMID: 18482589]doi: 10.1053/j.gastro.2008.03.040
16. Allison JE, Sakoda LC, Levin TR, Tucker JP, Tekawa IS, Cuff T, et al. Screening for colorectal neoplasms with new fecal occult blood tests: Update on performance characteristics. J Natl Cancer Inst. 2007;99: 1462-70. [PMID: 17895475]
17. Smith A, Young GP, Cole SR, Bampton P. Comparison of a brushsampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia. Cancer. 2006;107: 2152-9. [PMID: 16998938]
18. Lee JK, Liles EG, Bent S, Levin TR, Corley DA. Accuracy of fecal immunochemical tests for colorectal cancer: Systematic review and meta-analysis. Ann Intern Med. 2014;160: 171. [PMID: 24658694] doi: 10.7326/M13-1484
19. Krieger N. Overcoming the absence of socioeconomic data in medical records: Validation and application of a census-based methodology. Am J Public Health. 1992;82: 703-10. [PMID: 1566949]
20. Gordon NP. How does the adult Kaiser Permanente membership in northern California compare with the larger community? Oakland, CA: Kaiser Permanente Division of Research; 2006. Accessed at www.dor.kaiser.org/external/uploadedFiles/content/research/mhs/-2011-Revised-Site/Documents-Special-Reports/comparison-kaiser-vs-nonKaiser-adults-kpnc(1).pdf on 16 December 2016.
21. Koebnick C, Langer-Gould AM, Gould MK, Chao CR, Iyer RL, Smith N, et al. Sociodemographic characteristics of members of a large, integrated health care system: Comparison with US Census Bureau data. Perm J. 2012;16: 37-41. [PMID: 23012597]
22. CPT 2011 Professional Edition. Chicago: American Med Assoc; 2010.
23. Corley DA, Jensen CD, Marks AR, Zhao WK, de Boer J, Levin TR, et al. Variation of adenoma prevalence by age, sex, race, and colon location in a large population: Implications for screening and quality programs. Clin Gastroenterol Hepatol. 2013;11: 172-80. [PMID: 22985608] doi: 10.1016/j.cgh.2012.09.010
24. Adamo MB, Johnson CH, Ruhl JL, Dickie LA, eds. SEER Program Coding and Staging Manual 2013. Bethesda, MD: National Cancer Institute; 2013. Accessed at http://seer.cancer.gov/archive/manuals/2013/SPCSM-2013-maindoc.pdf on 14 December 2015.
25. Crotta S, Segnan N, Paganin S, Dagnes B, Rosset R, Senore C. High rate of advanced adenoma detection in 4 rounds of colorectal cancer screening with the fecal immunochemical test. Clin Gastroenterol Hepatol. 2012;10: 633-8. [PMID: 22426085] doi: 10.1016/j.cgh.2012.02.030
26. Parente F, Boemo C, Ardizzoia A, Costa M, Carzaniga P, Ilardo A, et al. Outcomes and cost evaluation of the first two rounds of a colorectal cancer screening program based on immunochemical fecal occult blood test in northern Italy. Endoscopy. 2013;45: 27-34. [PMID: 23254404] doi: 10.1055/s-0032-1325800
27. Faivre J, Dancourt V, Lejeune C, Tazi MA, Lamour J, Gerard D, et al. Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study. Gastroenterology. 2004;126: 1674-80. [PMID: 15188160]
28. Steele RJ, McClements PL, Libby G, Black R, Morton C, Birrell J, et al. Results from the first three rounds of the Scottish demonstration pilot of FOBT screening for colorectal cancer. Gut. 2009;58: 530-5. [PMID: 19036949] doi: 10.1136/gut.2008.162883
29. Gupta S, Halm EA, Rockey DC, Hammons M, Koch M, Carter E, et al. Comparative effectiveness of fecal immunochemical test outreach, colonoscopy outreach, and usual care for boosting colorectal cancer screening among the underserved: A randomized clinical trial. JAMA Intern Med. 2013;173: 1725-32. [PMID: 23921906]
30. Inadomi JM, Vijan S, Janz NK, Fagerlin A, Thomas JP, Lin YV, et al. Adherence to colorectal cancer screening: A randomized clinical trial of competing strategies. Arch Intern Med. 2012;172: 575-82. [PMID: 22493463] doi: 10.1001/archinternmed.2012.332
31. Quintero E, Castells A, Bujanda L, Cubiella J, Salas D, Lanas Á, et al; COLONPREV Study Investigators. Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N Engl J Med. 2012;366: 697-706. [PMID: 22356323] doi: 10.1056/NEJ Moa1108895
32. Rex DK, Petrini JL, Baron TH, Chak A, Cohen J, Deal SE, et al; ASGE/ACG Taskforce on Quality in Endoscopy. Quality indicators for colonoscopy. Am J Gastroenterol. 2006;101: 873-85. [PMID: 16635231]
33. Rex DK, Schoenfeld PS, Cohen J, Pike IM, Adler DG, Fennerty MB, et al. Quality indicators for colonoscopy. Gastrointest Endosc. 2015;81: 31-53. [PMID: 25480100] doi: 10.1016/j.gie.2014.07.058